Continued escitalopram reduces risk of relapse in people with generalised social anxiety disorder.
نویسنده
چکیده
منابع مشابه
Analysis of health-related quality of life and costs based on a randomised clinical trial of escitalopram for relapse prevention in patients with generalised social anxiety disorder
BACKGROUND Social anxiety disorder (SAD) is associated with substantial reduction in health-related quality of life (HRQoL). Escitalopram has proven efficacy in the short-term treatment of SAD and prevention of relapse. OBJECTIVES To determine whether the clinical effects of treatment translated into HRQoL benefits and to investigate costs of SAD treatment. METHODS Data on HRQoL and resourc...
متن کاملEscitalopram and paroxetine in the treatment of generalised anxiety disorder: randomised, placebo-controlled, double-blind study.
BACKGROUND It is uncertain whether higher doses of selective serotonin reuptake inhibitors have greater efficacy in generalised anxiety disorder. AIMS To assess the efficacy of different doses of escitalopram in generalised anxiety disorder. METHOD Randomised, double-blind, placebo-controlled, fixed-dose, parallel-group, 12-week study, with 681 patients: placebo (n=139); escitalopram, 5 mg/...
متن کاملCauses of Lapse and Relapse of Opioid Use: A Qualitative Study of High-Risk Situations in Iranian Women
Introduction: Substance use disorders are increasing in women, in contrast, withdrawal and failure in treatment have a high rate in them and it is necessary to identify the specific causes of female relapse. Therefore, the purpose of this study was to identify the factors affecting the relapse of substance use based on high-risk situations in Iranian women with opioid use disorder. Methods: Th...
متن کاملTherapeutic Advantages of Escitalopram in Depression and Anxiety Disorders
What are the therapeutic advantages of escitalopram, the purified S-enantiomer of the racemate citalopram? The biological activity and therapeutic effects of citalopram, which has been used for over a decade to effectively treat depression and other psychiatric disorders, have been shown to reside exclusively in escitalopram. Escitalopram has been shown in vitro to be more than twice as potent ...
متن کاملCognitive-behavioral therapy augmentation of SSRI reduces cortisol levels in older adults with generalized anxiety disorder: A randomized clinical trial.
OBJECTIVES Elevated cortisol in stress and aging, such as has been seen in late-life anxiety disorders, is postulated to accelerate cognitive and physiological decline in this large and increasing population. Selective serotonin-reuptake inhibitors (SSRIs) and cognitive-behavioral therapy (CBT) are both effective treatments for generalized anxiety disorder (GAD) in older adults. On the other ha...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Evidence-based mental health
دوره 9 2 شماره
صفحات -
تاریخ انتشار 2006